For research use only. Not for human consumption. Not medical advice — consult a licensed clinician.

Immune Modulator

Enclomiphene

Also known as: Androxal

Enclomiphene is the trans-stereoisomer of clomiphene citrate, a non-steroidal selective estrogen receptor modulator (SERM) that stimulates endogenous testosterone production. It is not a peptide, but is widely tracked in the peptide and TRT community as an off-label, compounded alternative to testosterone replacement therapy for men who wish to preserve fertility. Clomiphene itself is a ~60:40 mixture of enclomiphene (trans, estrogen-antagonist) and zuclomiphene (cis, weak long-acting estrogen-agonist); isolating the trans-isomer is intended to deliver the HPG-axis effect without the zuclomiphene-driven side effects.

Real-time market data

Pricing for Enclomiphene

Live vendor pricing, normalized to $/mg so sizes compare fairly — fused with each seller's Merit trust score and latest independent COA purity. Prices refresh daily.

Independent evidence

No COAs on file for Enclomiphene

No third-party tests indexed yet. Phase 2 will surface more vendor evidence as the dataset grows.

Research depth

28 citations indexed for Enclomiphene

All research on Enclomiphene →

Study · 2026

Changes in Serum Testosterone After Sublingual Enclomiphene Citrate Combined With a Mineral Oxide Delivery System: A Retrospective Case Series of 15 Men

Background Declining testosterone levels in adult males represent a significant clinical burden.

Study · 2026

British Society of Sexual Medicine: Position Statement for the Potential Use of Enclomiphene in the Treatment of Male Hypogonadism

review · 2026

Treatment Options for Improving The Semen Quality in Obese Men: A Scoping Review

Obesity is a significant factor affecting male fertility. Infertility in obese men often accompanies with metabolic dysfunction and differs from idiopathic male infertility (MI) in treatment approaches. This scoping review summarizes published treatment options for affecting the semen quality in obese men.

review · 2025

Preserving spermatogenesis in testosterone deficiency: innovations in replacement and stimulatory therapies

The rising prevalence of testosterone deficiency has led to increased use of exogenous testosterone therapy, including among men desiring fertility. Conventional testosterone replacement therapies (TRT) restore serum testosterone but suppress gonadotropins, resulting in impaired spermatogenesis.

review · 2025

Comment on Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials

meta-analysis · 2025

Clomiphene or enclomiphene citrate for the treatment of male hypogonadism: a systematic review and meta-analysis of randomized controlled trials

Objective This study aimed to evaluate the efficacy and safety of selective estrogen receptor modulators (SERMs), specifically clomiphene and enclomiphene, in treating men with functional hypogonadism.